Levi Garraway

Levi Garraway is a precision oncology leader who has contributed to the Cancer Genome Atlas and the genomic characterization of multiple tumor types. His academic work at Dana-Farber identified novel oncogenic drivers including MITF amplification in melanoma. He has bridged large-scale genomic discovery with therapeutic targeting and led oncology drug development at Roche/Genentech. His career represents the translational precision oncology pathway from genome-scale discovery to clinical application.